Business & Regulation

Bribery accusations, a new whistleblowing policy, and recalls... What’s new for pharma in business?

How does the FBI track down culprits of pharma heists?

Intrepid researchers scour disused mines in search of new biochemistries for drug development.

Celebrating the great and good of drug development: welcome to The Medicine Maker 2017 Power List

Should the UK National Health Service manufacture some generic drugs?

Marathon sells Emflaza, but questions remain about FDA approval processes.

Small molecule APIs have been a strong focus throughout Bernhard Paul's career.

Pharma has a number of underlying structural issues. It's time for a change of direction.

It's time to develop an ethical code for the pharmaceutical industry.

Today, the majority of the contract manufacturing market is made up of small molecules.